GBM-specific CSCs are categorized into pro-neural and mesenchymal subtypes with different molecular signatures, e.g., where CD133 and SOX2 are the markers for the pro-neural type of CSCs, CD44 belongs to the mesenchymal subtype [43]. Here, SOX2 is linked to glioblastoma.